Talking Biotech with Dr. Kevin Folta cover image

Joel Rurik: CAR-T Therapies to Reverse Cardiac Fibrosis

Talking Biotech with Dr. Kevin Folta

00:00

Is Fibrosis a Cancer?

We're hoping for about three to five years to start the first trials. We can use this a a tool to start understanding what fibrosis really means in the disease context. It modularizes treatment for really severe disease that currently doesn't have a treatment. And, you know, i think it really democratizes carte therapy.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app